Pyroptosis predicts immunotherapy outcomes across multiple cancer types
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference54 articles.
1. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat. Rev. Immunol.,2020
2. Top 10 challenges in cancer immunotherapy;Hegde;Immunity,2020
3. Five-year overall survival for patients with advanced nonsmall-cell lung cancer treated with Pembrolizumab: results from the phase I KEYNOTE-001 study;Garon;J. Clin. Oncol.,2019
4. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015
5. Multiomics prediction of response rates to therapies to inhibit programmed cell death 1 and programmed cell death 1 ligand 1;Lee;JAMA Oncol.,2019
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy;Life Sciences;2024-10
2. Research progress on the effect of pyroptosis on the occurrence, development, invasion and metastasis of colorectal cancer;World Journal of Gastrointestinal Oncology;2024-08-15
3. Encapsulation and release of calcein from herceptin-conjugated eLiposomes;Heliyon;2024-03
4. Role Of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer;International Journal of Biological Sciences;2024
5. Encapsulation and release of calcein from Herceptin- conjugated eLiposomes;2023-11-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3